Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial Pneumonia
Public ClinicalTrials.gov record NCT04160260. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1 Multi-Center Study to Measure the Pharmacokinetics of Oral Omadacycline in Adult Subjects With Community-Acquired Bacterial Pneumonia (CABP)
Study identification
- NCT ID
- NCT04160260
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Paratek Pharmaceuticals Inc
- Industry
- Enrollment
- 18 participants
Conditions and interventions
Conditions
Interventions
- Omadacycline Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 27, 2019
- Primary completion
- Mar 22, 2020
- Completion
- Apr 12, 2020
- Last update posted
- Nov 2, 2021
2019 – 2020
United States locations
- U.S. sites
- 13
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 105 | Birmingham | Alabama | 35215 | — |
| Site 102 | San Diego | California | 92123 | — |
| Site 104 | San Diego | California | 92123 | — |
| Site 111 | Clearwater | Florida | 33756 | — |
| Site 116 | Clearwater | Florida | 33756 | — |
| Site 106 | Doral | Florida | 33166 | — |
| Site 108 | Miami | Florida | 33155 | — |
| Site 110 | Miami | Florida | 33165 | — |
| Site 112 | West Palm Beach | Florida | 33409 | — |
| Site 103 | Butte | Montana | 59701 | — |
| Site 114 | Las Vegas | Nevada | 89106 | — |
| Site 101 | Sherman | Texas | 75092 | — |
| Site 109 | Madison | Wisconsin | 53717 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04160260, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 2, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04160260 live on ClinicalTrials.gov.